Cappuccio F P, Markandu N D, Buckley M G, Sagnella G A, Shore A C, MacGregor G A
Clin Sci (Lond). 1987 May;72(5):531-9. doi: 10.1042/cs0720531.
Plasma levels of atrial natriuretic peptide (ANP) were measured by radioimmunoassay in eight normal healthy volunteers before and during mineralocorticoid escape. Mean plasma ANP on a fixed sodium intake before fludrocortisone was 6.5 +/- SEM 1.1 pg/ml. Within 24 h of fludrocortisone administration there was a significant increase in plasma ANP which continued to increase daily reaching a plateau by day 4 (14.9 +/- 2.4 pg/ml) to day 7 (15.1 +/- 2.6 pg/ml). The rise in plasma ANP was closely related to the amount of sodium retained during the fludrocortisone treatment and the sodium 'escape' occurred by days 4 to 7. These results support the concept that ANP could play an important hormonal role in over-coming the sodium-retaining effects of mineralocorticoids in man.
通过放射免疫分析法测量了8名正常健康志愿者在盐皮质激素逃逸前及期间的血浆心房利钠肽(ANP)水平。在服用氟氢可的松前,固定钠摄入量时的平均血浆ANP为6.5±标准误1.1皮克/毫升。在服用氟氢可的松的24小时内,血浆ANP显著升高,并持续每日升高,到第4天(14.9±2.4皮克/毫升)至第7天(15.1±2.6皮克/毫升)达到平台期。血浆ANP的升高与氟氢可的松治疗期间保留的钠量密切相关,钠“逃逸”发生在第4至7天。这些结果支持了ANP在克服盐皮质激素对人体的钠潴留作用中可能发挥重要激素作用的概念。